FAQs

Reconcile-90ct-Group-scaled

SEPARATION ANXIETY

RECONCILE®

BOND® BEHAVIOR MODIFICATION TRAINING

References

  1. Parthasarathy V, Crowell-Davis SL. Relationship between attachment to owners and separation anxiety in pet dogs (Canis lupus familiaris). J Vet Behav. 2006;1:109-120.
  2. Schwartz S. Separation anxiety syndrome in dogs and cats. J Am Vet Med Assoc. 2003;22(11):1526-1532.
  3. Blackwell E, Casey RA, Bradshaw WS. Controlled trial of behavioural therapy for separation-related disorders in dogs. Vet Rec. 2006;158:51-554.
  4. Horwitz DF. Separation anxiety in dogs. NAVC Clinician's Brief. 2008;11:61-62.
  5. Takeuchi Y, Houpt KA, Scarlett JM. Evaluation of treatments for separation anxiety in dogs. J Am Vet Med Assoc. 2000;17(3):342-345.
  6. Simpson BS, Landsberg GM, Reisner IR, et al. Effects of Reconcile (fluoxetine) chewable tablet plus behavior management for canine separation anxiety. Vet Ther. 2007:8(1):18-31.
  7. Pharmacokinetic study D00901. Freedom of Information Summary NADA 141-272; Reconcile Fluoxetine Hydrochloride Chewable Tablets: Dogs. 2007:11.
  8. PRN Pharmacal, Reconcile Product label, 2018.
  9. Toxicity study D3760. Freedom of Information Summary NADA 141-272; Reconcile Fluoxetine Hydrochloride Chewable Tablets: Dogs. 2007:9.